Improving Information Exchange with Clinical Trial Participants: A Proposal for Industry
Improving Information Exchange with Clinical Trial Participants: A Proposal for Industry
复制标题
DOI：
10.1177/2168479017725109
复制
发表时间：
2017-09-01
影响因子：
1.5
通讯作者：
Jakee, Kelsey
中科院分区：
文献类型：
--
作者：
Dietrich, Julie;Alivojvodic, Jeannine;Jakee, Kelsey
背景：研究人员越来越倾向于以患者为中心的药物开发。Transmartate已将改善信息交换视为为患者及其医疗保健专业人员（HCP）创造更满意的临床试验体验的重要组成部分。方法：患者、申办者、研究中心和HCP通过调查、访谈，和/或咨询委员会，以获取信息交换的当前状态，并确定临床研究中主要利益相关者之间未来可能的实践结果：数据表明，患者在他们的临床试验旅程期间对信息交换有许多愿望和偏好，这些愿望和偏好通常不被满足。存在各种机会，以改善临床试验参与者的经验，通过改善信息交流的做法，在各个阶段的参与者的journey.Conclusions：在行业的重点转向更全面的信息交流与试验参与者有可能产生积极的影响，许多患者。
Background: Researchers are increasingly motivated to move toward patient-centric drug development. TransCelerate has identified improved information exchange as an important component of creating a more satisfying clinical trial experience for patients and their health care professionals (HCPs).Methods: Patients, sponsors, sites, and HCPs were engaged through surveys, interviews, and/or advisory boards to capture the current status of information exchange and identify possible future practices between the major stakeholders within the clinical research ecosystem.Results: Data suggest that patients have numerous desires and preferences for information exchange during their clinical trial journey that are not commonly met. Various opportunities exist to improve the clinical trial participants' experiences by improving information exchange practices across various stages of the participant's journey.Conclusions: A shift in industry focus toward more comprehensive information exchange with trial participants has the potential to positively impact many patients.